 |
(1R,2R,3R,5S)-3-(4-Methylphenyl)-8-(2-phenylethyl)-2-phenyl-8-azabicyclo[3.2.1]octane |
|
C28H31N |
 |
5′-[2(S)-Amino-N-hydroxy-4-(methylsulfanyl)butanamido]-5′-desoxyadenosine trifluoroacetate |
|
C15H23N7O5S.C2HF3O2 |
|
|
(-)-(R,R)-N-Cyclopropyl-N-(2-hydroxycyclohexyl)-N’-[3-(2-oxo-1,2-dihydroquinolin-6-yloxy)propyl]urea |
|
C22H29N3O4 |
|
|
9-Hydroxy-2-(3-methoxy-2-oxopropoxy)-5,11-dimethyl-6H-pyrido[4,3-b]carbazolium bromide; 9-Hydroxy-2-(3-methoxy-2-oxopropoxy)ellipticinium bromide |
153532-59-3 |
C21H21N2O4.Br |
|
|
5-(Imidazo[1,2-a]pyridin-6-yl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile hydrochloride monohydrate |
119615-63-3 (anhydrous); 106730-54-5 (anhydrous fr |
C14H10N4O.ClH.H2O |
|
|
(±)-(2R*,5Z,9S*,10S*,16R*)-9-[N-[2-(1-Pyrrolidinyl)ethyl]carbamoyloxy]-10,2,10-(epoxymetheno)-1-benz[b]azacyclododeca-5-ene-3,7-diyne-1-carboxylic acid 4-chlorophenyl ester hydrochloride,mixture with the (2R*,5Z,9R*,10S*,16R*)-isomer (2:1) |
|
C30H26ClN3O5.ClH |
|
|
3-[(2-Morpholinoethyl)amino]-6-phenyl-4-pyridazinecarbonitrile |
094011-82-2 |
C17H19N5O |
|
|
2-Cyano-1-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]-3-(2-propynyl)guanidine hydrochloride; N-Cyano-N’-[2-[(5-methyl-4-imidazolyl)methylthio]ethyl]-N”-propargylguanidine hydrochloride |
071807-56-2; 069539-53-3 (free base) |
C12H16N6S.ClH |
|
|
(6R,7R)-7-[2-(2-Aminothiazol-4-yl)-2(Z)-(methoxyimino)acetamido]-3-[2(Z)-(4-methylthiazol-5-yl)vinyl]-3-cephem-4-carboxylic acid pivaloyloxymethyl ester; (6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-8-oxo-5-thia-1 |
117467-28-4 |
C25H28N6O7S3 |
|
|
(2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S)(triethylphosphine)gold; (1-Thio-beta-D-glucopyranosato-S)(triethylphosphine)gold 2,3,4,6-tetraacetate |
034031-32-8 |
C14H19AuO9S.C6H15P |
